Newer quinolones able to tackle many ocular surface bacteria


Stanford, CA-In vitro susceptibility test results demonstrate that the newer, 8-methoxy fluoroquinolones gatifloxacin (Zymar, Allergan) and moxifloxacin (Vigamox, Alcon) outperform older fluoroquinolones in their activity against gram-positive ocular isolates, including those with resistance to multiple other antibiotics, said Herminia Mi?o de Kaspar, PhD, senior research associate, department of ophthalmology, Stanford University, Stanford, CA.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.